Therapy for Stage IV Non-Small Cell Lung Cancer With and Without Driver Alterations: ASCO Living Guideline Clinical Insights

被引:3
作者
Owen, Dwight H. [1 ]
Jaiyesimi, Ishmael A. [2 ,3 ]
Leighl, Natasha B. [4 ]
Ismaila, Nofisat [5 ]
Florez, Narjust [6 ]
Puri, Sonum [7 ]
Schenk, Erin L. [8 ]
Schneider, Bryan J. [9 ]
Patel, Jyoti D. [10 ]
机构
[1] Ohio State Univ, Columbus, OH 43210 USA
[2] Corewell Hlth William Beaumont Univ Hosp, Royal Oak, MI USA
[3] Oakland Univ, William Beaumont Sch Med, Rochester, MI USA
[4] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada
[5] Amer Soc Clin Oncol ASCO, Alexandria, VA USA
[6] Harvard Med Sch, Dana Farber Canc Inst, Boston, MA USA
[7] Huntsman Canc Inst, Salt Lake City, UT USA
[8] Univ Colorado, Anschutz Med Ctr, Aurora, CO USA
[9] Univ Michigan Hlth Syst, Ann Arbor, MI USA
[10] Northwestern Univ, Chicago, IL USA
关键词
PHASE-III TRIAL; DOCETAXEL; OUTCOMES; PLUS;
D O I
10.1200/OP.24.00177
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
[No abstract available]
引用
收藏
页码:893 / 898
页数:7
相关论文
共 23 条
[1]   Datopotamab deruxtecan (Dato-DXd) vs docetaxel in previously treated advanced/metastatic (adv/met) non-small cell lung cancer (NSCLC): Results of the randomized phase III study TROPION-Lung01 [J].
Ahn, M. J. ;
Lisberg, A. ;
Paz-Ares, L. ;
Cornelissen, R. ;
Girard, N. ;
Pons-Tostivint, E. ;
Baz, D. Vicente ;
Sugawara, S. ;
Dols, M. Cobo ;
Perol, M. ;
Mascaux, C. ;
Poddubskaya, E. ;
Kitazono, S. ;
Hayashi, H. ;
Sands, J. ;
Hall, R. ;
Zhang, Y. ;
Zebger-Gong, H. ;
Uema, D. ;
Okamoto, I. .
ANNALS OF ONCOLOGY, 2023, 34 :S1305-S1306
[2]   Gemcitabine plus best supportive care (BSC) vs BSC in inoperable non-small cell lung cancer - a randomized trial with quality of life as the primary outcome [J].
Anderson, H. ;
Hopwood, P. ;
Stephens, R. J. ;
Thatcher, N. ;
Cottier, B. ;
Nicholson, M. ;
Milroy, R. ;
Maughan, T. S. ;
Falk, S. J. ;
Bond, M. G. ;
Burt, P. A. ;
Connolly, C. K. ;
McIllmurray, M. B. ;
Carmichael, J. .
BRITISH JOURNAL OF CANCER, 2000, 83 (04) :447-453
[3]   Pembrolizumab Plus Pemetrexed and Platinum in Nonsquamous Non-Small-Cell Lung Cancer: 5-Year Outcomes From the Phase 3 KEYNOTE-189 Study [J].
Garassino, Marina C. ;
Gadgeel, Shirish ;
Speranza, Giovanna ;
Felip, Enriqueta ;
Esteban, Emilio ;
Domine, Manuel ;
Hochmair, Maximilian J. ;
Powell, Steven F. ;
Bischoff, Helge G. ;
Peled, Nir ;
Grossi, Francesco ;
Jennens, Ross R. ;
Reck, Martin ;
Hui, Rina ;
Garon, Edward B. ;
Kurata, Takayasu ;
Gray, Jhanelle E. ;
Schwarzenberger, Paul ;
Jensen, Erin ;
Pietanza, M. Catherine ;
Rodriguez-Abreu, Delvys .
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (11) :1992-+
[4]   Associations of Tissue Tumor Mutational Burden and Mutational Status With Clinical Outcomes With Pembrolizumab Plus Chemotherapy Versus Chemotherapy For Metastatic NSCLC [J].
Garassino, Marina C. ;
Gadgeel, Shirish ;
Novello, Silvia ;
Halmos, Balazs ;
Felip, Enriqueta ;
Speranza, Giovanna ;
Hui, Rina ;
Garon, Edward B. ;
Horinouchi, Hidehito ;
Sugawara, Shunichi ;
Rodriguez-Abreu, Delvys ;
Reck, Martin ;
Cristescu, Razvan ;
Aurora-Garg, Deepti ;
Loboda, Andrey ;
Lunceford, Jared ;
Kobie, Julie ;
Ayers, Mark ;
Piperdi, Bilal ;
Pietanza, M. Catherine ;
Paz-Ares, Luis .
JTO CLINICAL AND RESEARCH REPORTS, 2023, 4 (01)
[5]  
Garassino Marina Chiara, 2022, J CLIN ONCOL, V40
[6]   Association of Circulating Tumor DNA Testing Before Tissue Diagnosis With Time to Treatment Among Patients With Suspected Advanced Lung Cancer: The ACCELERATE Nonrandomized Clinical Trial [J].
Garcia-Pardo, Miguel ;
Czarnecka-Kujawa, Kasia ;
Law, Jennifer H. ;
Salvarrey, Alexandra M. ;
Fernandes, Roxanne ;
Fan, Zhen J. ;
Waddell, Thomas K. ;
Yasufuku, Kazuhiro ;
Liu, Geoffrey ;
Donahoe, Laura L. ;
Pierre, Andrew ;
Le, Lisa W. ;
Gunasegaran, Tharsiga ;
Ghumman, Noor ;
Shepherd, Frances A. ;
Bradbury, Penelope A. ;
Sacher, Adrian G. ;
Schmid, Sabine ;
Corke, Lucy ;
Feng, Jamie ;
Stockley, Tracy ;
Pal, Prodipto ;
Rogalla, Patrik ;
Pipinikas, Christodoulos ;
Howarth, Karen ;
Ambasager, Bana ;
Mezquita, Laura ;
Tsao, Ming S. ;
Leighl, Natasha B. .
JAMA NETWORK OPEN, 2023, 6 (07)
[7]   Cemiplimab plus chemotherapy versus chemotherapy alone in non-small cell lung cancer: a randomized, controlled, double-blind phase 3 trial [J].
Gogishvili, Miranda ;
Melkadze, Tamar ;
Makharadze, Tamta ;
Giorgadze, Davit ;
Dvorkin, Mikhail ;
Penkov, Konstantin ;
Laktionov, Konstantin ;
Nemsadze, Gia ;
Nechaeva, Marina ;
Rozhkova, Irina ;
Kalinka, Ewa ;
Gessner, Christian ;
Moreno-Jaime, Brizio ;
Passalacqua, Rodolfo ;
Li, Siyu ;
McGuire, Kristina ;
Kaul, Manika ;
Paccaly, Anne ;
Quek, Ruben G. W. ;
Gao, Bo ;
Seebach, Frank ;
Weinreich, David M. ;
Yancopoulos, George D. ;
Lowy, Israel ;
Gullo, Giuseppe ;
Rietschel, Petra .
NATURE MEDICINE, 2022, 28 (11) :2374-+
[8]   Randomized phase III trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy [J].
Hanna, N ;
Shepherd, FA ;
Fossella, FV ;
Pereira, JR ;
De Marinis, F ;
von Pawel, J ;
Gatzemeier, U ;
Tsao, TCY ;
Pless, M ;
Muller, T ;
Lim, HL ;
Desch, C ;
Szondy, K ;
Gervais, R ;
Shaharyar ;
Manegold, C ;
Paul, S ;
Paoletti, P ;
Einhorn, L ;
Bunn, PA .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (09) :1589-1597
[9]   Concurrent Tissue and Circulating Tumor DNA Molecular Profiling to Detect Guideline-Based Targeted Mutations in a Multicancer Cohort [J].
Iams, Wade T. ;
Mackay, Matthew ;
Ben-Shachar, Rotem ;
Drews, Joshua ;
Manghnani, Kabir ;
Hockenberry, Adam J. ;
Cristofanilli, Massimo ;
Nimeiri, Halla ;
Guinney, Justin ;
Benson III, Al B. .
JAMA NETWORK OPEN, 2024, 7 (01)
[10]   Immunotherapy Treatment Patterns and Outcomes Among ALK-Positive Patients With Non-Small-Cell Lung Cancer [J].
Jahanzeb, Mohammad ;
Lin, Huamao M. ;
Pan, Xiaoyun ;
Yin, Yu ;
Baumann, Pia ;
Langer, Corey J. .
CLINICAL LUNG CANCER, 2021, 22 (01) :49-57